Stage II Trial of Capecitabine Joined Together with Thalidomide in Second-Line Medicine of Progressed Pancreatic Growth

Shi Sheng-bin, Wang Meng, Niu Zuo-xing^*, Tang Xiao-yong and Quan Yun-Liu

Department of Internal Medicine, Shan Dong Tumor Hospital, China

^*Corresponding Author: Niu Zuo-xing, Department of Internal Medicine, Shan Dong Tumor Hospital, Jinan, 250117, PR China, Tel: 86+531-67626341, Fax: 86+531-67626341 Email: